Treatment of mania, mixed state, and rapid cycling

Canadian Journal of Psychiatry

Volumn 42, Issue SUPPL. 2, 1997, Pages

  Kusumakar, Vivek ^a   Yatham, Lakshmi N ^b   Haslam, David R S ^a   Parikh, Sagar V ^c,d   Matte, Raymond ^e   Silverstone, Peter H ^f   Sharma, Verinder ^g  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Benzodiazepines; Carbamazepine; Divalproex sodium; Electroconvulsive therapy; Lithium; Mania; Mixed state; Neuroleptics; Rapid cycling

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; LAMOTRIGINE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; VALPROATE SEMISODIUM;

BIOLOGICAL RHYTHM; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; HUMAN; MANIA; MOOD; REVIEW; TREATMENT PLANNING;

BIPOLAR DISORDER; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; HUMANS; PRACTICE GUIDELINES; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS;

EID: 0030752841     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Cummings JL. Organic psychoses: delusional disorders and secondary mania. Psychiatr Clin North Am 1986;9:293-311.
2. Jorge RE, Starkstein SE, Arndt SV, Forrester AW, Geisler FH. Secondary mania following traumatic brain injury. Am J Psychiatry 1993;150:916-21.
3. Krauthammer C, Klerman GL. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiatry 1978;35:1333-9.
4. Stratowski SM, McElroy SL, Keck PE. The co-occurance of mania with medical and other psychiatric disorders. Int J Psychiatry Med 1994;24:305-28.
5. Devanand DP, Sackeim HA, Decina P, Prudic J. The development of mania and organic euphoria during ECT. J Clin Psychiatry 1988;49:69-71.
6. Srisurapanont M, Yatham LN, Zis AP. Treatment of acute bipolar depression: a review of the literature. Can J Psychiatry 1995;40:533-44.
7. Ehlers CL, Kupfer DJ, Frank E, Monk TH. Biological rhythms and depression: the role of Zeitgebers and zeitstorers. Depression 1993:1:285-93.
8. Camfield P, Camfield C, Dooley J, Farrell K, Humphreys P, Langevin P. Routine screening of blood and urine for severe reactions to anticonvulsant drugs in asymptomatic patients is of doubtful value. Can Med Assoc J 1989;140:1303-5.
9. Pellock JM, Willmore LJ. A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. Neurology 1991;41:961-4.
10. Kusumakar V, Yatham LN, Parikh SV, Matte R. Sharma V, Silverstone P, and others. Bipolar disorder: a summary of clinical issues and treatment options. CANMAT Monograph. Halifax (NS): 1997. 04. 001. p 28-39.
11. Goodwin FK, Ebert M. Lithium in mania: clinical trials and controlled studies. In: Gershon S, Shopsin B, editors. Lithium: its role in psychiatric research and treatment. New York: Plenum; 1973. p 22-41.
12. Goodwin FK, Zis AP. Lithium in the treatment of mania: comparisons with neuroleptics. Arch Gen Psychiatry 1979;36:840-4.
13. Bowden CL, Brugger A, Swann AC, Calabrese JR, Janicak PG, Petty F, and others. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-24.
14. Maggs R. Treatment of manic illness with lithium carbonate. Br J Psychiatry 1963;109:56-65.
15. Goodwin FK, Murphy DL, Bunney WF Jr. Lithium carbonate treatment in depression and mania: a double-blind study. Arch Gen Psychiatry 1969;21:486-96.
16. Stokes PE, Shamoian CA, Stoll PM, Patton MJ. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971;1:1319-25.
17. Johnson G, Gershon S, Burdock EI. Floyd A, Hekimian L. Comparative effects of lithium and chlorpromazine in treatment of acute manic states. Br J Psychiatry 1971;119:267-76.
18. Spring G, Schweid D, Gray G, Steinberg J, Horwitz M. A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. Am J Psychiatry 1970:126:1306-10.
19. Prien RF, Cafley EM Jr, Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiatry 1972;26:146-53.
20. Melia PI. Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 1970;116:621-1.
21. Keck PE, McElroy SL. Current perspectives on treatment of bipolar disorder with lithium. Psychiatric Annals 1993;23:64-9.
22. Kane JM. The role of neuroleptics in manic-depressive illness. J Clin Psychiatry 1988;49 Suppl 1:12S-13S.
23. McElroy SL, Keck PE Jr, Strakowski SM. Mania, psychosis, and antipsychotics. J Clin Psychiatry 1996;57 Suppl 3:14S-26S.
24. Calabrese JR, Fatemi H, Kujawa M, Woyshville MJ. Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996;16 Suppl 1:24S-31S.
25. Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ, and others. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986;255:3138-42.
26. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Valproate in treatment of bipolar disorder: literature review and clinical guidelines. J Clin Psychopharmacol 1992;12 Suppl 1:42S-52S.
27. McElroy SL, Keck PE Jr. Treatment guidelines for valproate in bipolar and schizoaffective disorders. Can J Psychiatry 1993;38 Suppl 2:62S-66S.
28. Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992; 12 Suppl 1:53S-56S.
29. Clothier JL, Swann AC, Freeman T. Dysphoric mania. J Clin Psychopharmacol 1992;12 Suppl 1:13S-16S.
30. Himmelhoch JM, Garfinkel ME. Mixed mania, diagnosis and treatment: sources of lithium resistance in mixed mania. Psychopharmacol Bull 1986;22:613-20.
31. Prien RF, Himmelhoch JM, Kupfer DJ. Treatment of mixed mania. J Affect Disord 1988;15:9-15.
32. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, and others. Depression during mania: treatment response to lithium or divalproex. Arch Gen Psychiatry 1997;54:37-42.
33. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991:48:62-8.
34. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-11.
35. McElroy SL, Keck PE Jr, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996;57:142-6.
36. Okuma T, Inanaga K, Otsuki S. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. Psychopharmacology 1979; 66:211-7.
37. Okuma T, Yamashita I. Takahashi R, Itoh H, Otsuki S, Wantanabe S. and others. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 1990;23:143-50.
38. Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 1986;47:490-4.
39. Lerer B, Moore N, Meyendorff E, Cho S-R, Gershon S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987;48:89-93.
40. Lusznat RM, Murphy DP, Nunn CMH. Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988;153:198-204.
41. Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Correlates of antimanic response to carbamazepine. Psychiatry Res 1987;21:71-83.
42. Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980;137:782-90.
43. Keck PE Jr, McElroy SL, Nemeroff CB. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:395-405.
44. Lipinski JH, Pope HJ Jr. Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients. Am J Psychiatry 1982;139:948-9.
45. Keck PE Jr, McElroy SL. Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol 1996;16 Suppl 1:15S-23S.
46. Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 1993;27:138-45.
47. Calabrese JR, Fatemi SH, Woyshville MJ. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder [letter]. Am J Psychiatry 1996;153:1236.
48. Bradwejn J, Shriqui C, Koszycki D, Meterissian G. Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. J Clin Psychopharmacol 1990;10:403-8.
49. Chouinard G, Young SN, Annable L. Antimanic effect of clonazepam. Biol Psychiatry 1983;18:451-6.
50. Edwards R, Stephenson U, Flewett T. Clonazepam in acute mania: a double blind trial. Aust N Z J Psychiatry 1991;25:238-42.
51. Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. Adjunctive treatment of manic agitation with lorazepem versus haloperidol: a double-blind study. J Clin Psychiatry 1992;53:47-52.
52. Chouinard G, Annable L, Turnier L, Holobow N, Szkrumelak N. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. Can J Psychiatry 1993;38 Suppl 4:114S-122S.
53. Sachs GS, Weilburg JB, Rosenbaum JF. Clonazepam vs neuroleptics as adjuncts to lithium maintenance. Psychopharmacol Bull 1990;26:137-43.
54. Miller NS, Gold MS. Abuse, addiction, tolerance, and dependance to benzodiazepines in medical and nonmedical populations. Am J Drug Alcohol Abuse 1991;17:27-37.
55. Busto V, Sellers EM, Naranjo CA, Cappell HD, Sanchez-Craig M, Simpkins J. Patterns of benzodiazepine abuse and dependance. British Journal of Addiction 1986;81:87-94.
56. Garfinkel PE, Stancer HC, Persad EA. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 1980;2:279-88
57. Takahashi R, Sakuma A, Itoh K, Itoh H, Kurihara M, Saito M, and others. Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Arch Gen Psychiatry 1975;32:1310-8.
58. Baastrup PC, Alhfors UG, Bjerkenstedt L, Dencker SJ, Fensbo C, Gravem A, and others. A controlled Nordik multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis. Acts Psychiatr Scand 1993;87:48-58.
59. Rifkin A, Basawaraj K, Doddi S, Cooper T. Dose and blood levels of haloperidol in treatment of mania. Psychopharmacol Bull 1990;26:144-6.
60. Platman SR. A comparison of lithium carbonate and chlorpromazine in mania. Am J Psychiatry 1970;127:351-3.
61. Janicak PG, Bresnahan DB, Sharma R, Davis JM, Comaty JE, Malinick C. A comparison of thiothixene with chlorpromazine in the treatment of mania. J Clin Psychopharmacol 1988;8:33-7.
62. McElroy SL. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-4.
63. Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992;32:270-80.
64. Banov MD, Zarate CA Jr, Tohen M, Scialabba D. Wines JD Jr, Kolbrener M, and others. Clozapine therapy in refractory affective disorders: polarity predicts response in long term follow-up. J Clin Psychiatry 1994;55:295-300.
65. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine therapy in severe mood disorders. J Clin Psychiatry 1995;56:108-12.
66. Ghaemi SN, Sachs GS, Baldassano CF. Management of bipolar disorder with adjunctive risperidone: response to open treatment. In: New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association; 1995 May 22; Miami, FL; Abstract NR 82:77.
67. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 1995;56:423-9.
68. Tohen M, Zarate CA Jr, Centorrino F. Risperidone in the treatment of mania. In: New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association; 1995 May 22; Miami, FL; Abstract NR 286:132.
69. Keck PE Jr, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balistreri TM, and others. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995;56:466-70.
70. McIntyre R, Young LT, Hasey G, Patelis-Siotis I, Jones BD. Risperidone treatment of bipolar disorder [letter]. Can J Psychiatry 1997;42:88-90.
71. Calabrese JR. Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, and others. Clozapine for treatment-refractory mania. Am J Psychiatry 1996;153:759-70.
72. Parsa MA, Ramirez LF, Loula EC, Meltzer HY. Effect of clozapine on psychotic depression and Parkinsonism. J Clin Psychopharmacol 1991;11:330-1.
73. Dwight MM, Keck PE Jr. Stanton SP, Strakowski SM, McElroy SL. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet 1994;344:554-5.
74. Mukherjee S, Sackheim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 1994;151:169-76.
75. Small JG, Klapper MH, Kellams JJ, Miller MJ. Milstein V. Sharpley PH, and others. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 1988;45:727-32.
76. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990;31:287-96.
77. American Psychiatrie Association. Practice guidelines for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151 Suppl 1:1S-36S.
78. Small JG, Kellams JJ, Milstein V, Small IF. Complications with electroconvulsive treatment combined with lithium. Biol Psychiatry 1985;20:125-34.
79. Rudorfer MV, Linnoila M, Potter WZ. Combined lithium and electroconvulsive therapy: pharmacokinetic and pharmacodynamic interactions. Convuls Ther 1987;3:40-5.
80. El-Mallakh RS. Complications of concurrent lithium and electroconvulsive therapy: a review of clinical material and theoretical considerations. Psychopharmacol Bull 1987;23:595-601.
81. Stromgren LS, Dahl J. Fjeldborg N, Thomsen A. Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy: anaesthestics and benzodiazepines. Acta Psychiatr Scand 1980;62:158-65.
82. Bowden CL. Role of newer medications for bipolar disorder. J Clin Psychopharmacol 1996;16 Suppl 1:48S-55S.
83. Dubovsky SL. Calcium antagonists in manic-depressive illness. Neuropsychobiology 1993;27:184-92.
84. Dubovsky SL, Buzan R. The role of calcium channel blockers in the treatment of psychiatric disorders. CNS Drugs 1995;4:47-57.
85. Janicak PG, Pandey G, Sharma RP, Peterson J, Leach A, Davis JM. Verapamil versus placebo for acute mania. Preliminary results of a double-blind study. In: 148th Annual Meeting of the American Psychiatric Association; 1995 May 22; Miami, FL. Abstract NR 86:144.
86. Barton BM, Gitlin MJ. Verapamil in treatment-resistant mania: an open trial. J Clin Psychopharmacol 1987;7:101-3.
87. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press; 1990.
88. Pope HG. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of specificity of "schizophrenic" symptoms in light of current research. Arch Gen Psychiatry 1978;35:811-28.
89. Tohen M, Tsuang MT, Goodwin DC. Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. Am J Psychiatry 1992;149:1580-4.
90. White E, Cheung P, Silverstone T. Depot antipsychotics in bipolar affective disorder. Int Clin Psychopharmacol 1993;8:119-22.
91. Morgan HG. The incidence of depressive symptoms during recovery from hypomania. Br J Psychiatry 1972;120:537-9.
92. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatr Neuropsychopharmakol 1980;13:156-67.
93. Ahlfors UG. Baastrup PC, Dencker SJ, Eigen K, Lingjaerde O, Pedersen V, and others. Flupenthixol decanoate in recurrent manic-depressive illness. Acta Psychiatr Scand 1981;64:226-37.
94. Levine S. The management of resistant depression. Acta Psychiatr Belg 1986: 86:141-51.